A Study to Evaluate the Efficacy and Safety of OTX-TIC (Travoprost) Intracameral Implant for Patients With Open-angle Glaucoma (OAG) or Ocular Hypertension (OHT)

Phase 2 Completed 83 enrolled Ocular Therapeutix, Inc.

RandomizedParallel-groupDouble-blindTreatment

Summary

To assess efficacy, and safety of a single sustained release dose of the OTX-TIC drug product (2 travoprost dose strengths) in subjects with Open Angle Glaucoma (OAG) or Ocular Hypertension (OHT)

Timeline

Start: 2022-03-16
Primary completion: 2024-01-24
Completion: 2025-01-24

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Bimatoprost	Other / unclassified	10 ug	Other
Subject	Travoprost	Other / unclassified	—	Other

A Study to Evaluate the Efficacy and Safety of OTX-TIC (Travoprost) Intracameral Implant for Patients With Open-angle Glaucoma (OAG) or Ocular Hypertension (OHT)

Summary

Timeline

Drugs

Indications